CAI vs CMS · rev $216.8M vs P/E 20, $22.42B cap
Caris Life Sciences, Inc. Common Stock (CAI) versus CMS Energy Corporation (CMS) — a side-by-side from cached financials, not a winner call.
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
CMS Energy Corporation (CMS) is a utilities - regulated electric company listed on US.
Latest reported CAI revenue for 2025-09-30 was $216.8M. Net income was $24.3M. Revenue was up 19.5% from 2025-06-30 to 2025-09-30. CAI currently screens at market cap $5.22B.
CMS does not have a complete income-statement cache yet.
CAI currently screens at market cap $5.22B. CMS currently screens at market cap $22.42B and trailing P/E 20.1.
Not investment advice. Open the CAI and CMS stock pages for the full models.
Not investment advice.